NPHLA Intelligence
Clinical Trial Watch
Trials NPHLA follows, synchronised from ClinicalTrials.gov. We flag what matters (new registrations, changes in status and newly posted results) and ignore routine record edits. Every therapy in a trial is investigational.
- Treatment for "Asymmetric Crying Facies"
Xiaolei Jin. Conditions: Hemifacial Microsomia; Facial Nerve Paralysis. Investigational — not approved for the use studied.
- ASSET: Autologous Fat Grafting for the Treatment of Chronic Tendinopathy
Weill Medical College of Cornell University. Conditions: Chronic Tendinopathy. Investigational — not approved for the use studied.
- Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd.. Conditions: Moderate to Severe Glabellar Lines. Investigational — not approved for the use studied.
- Platelet-Rich Plasma for Peyronie's Disease
Herlev Hospital. Conditions: Peyronies Disease. Investigational — not approved for the use studied.
- ENIGI: A European Network for the Investigation of Gender Incongruence
University Hospital, Ghent. Conditions: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons. Investigational — not approved for the use studied.
- SERCABOT: Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
Centre Oscar Lambret. Conditions: Post-Mastectomy Neuropathic Pain Syndrome. Investigational — not approved for the use studied.
- Acupuncture of Different Treatment Frequency in Chronic Plantar Fasciitis
Guang'anmen Hospital of China Academy of Chinese Medical Sciences. Conditions: Plantar Fasciitis, Chronic. Investigational — not approved for the use studied.
- A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
AbbVie. Conditions: Glabellar Lines. Investigational — not approved for the use studied.
- A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
Wake Forest University Health Sciences. Conditions: Central Centrifugal Cicatricial Alopecia. Investigational — not approved for the use studied.
- KDKR26: Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy
K. Kay Durairaj, MD, FACS, A Medical Corporation. Conditions: Androgenic Alopecia; Female Pattern Hair Loss; Hair Loss. Investigational — not approved for the use studied.
- A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
Chong Kun Dang Pharmaceutical. Conditions: Androgenetic Alopecia. Investigational — not approved for the use studied.
- Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia
Absci Pty Ltd.. Conditions: Androgenetic Alopecia (AGA); Healthy Volunteers - Male and Female. Investigational — not approved for the use studied.
- Botulinum Toxin Type A for Wound Healing After Laparoscopic Colectomy
Pham Ngoc Thach University of Medicine. Conditions: Surgical Wound Healing; Botulinum Toxin, Type A. Investigational — not approved for the use studied.
- BoTox Into the Sternocleidomastoid Muscles (SCM)
Boston Medical Center. Conditions: Neck Muscle Issue. Investigational — not approved for the use studied.
- Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Conditions: Wrinkle; Glabellar Frown Lines; Glabellar Furrowing. Investigational — not approved for the use studied.
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Trial listings are not recommendations to enrol or prescribe.